Maintenance Therapy: Clinical Trials

3 trials for Maintenance Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 not yet recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Not yet recruiting 1

Follow Maintenance Therapy: new trials by email Literature Review of Maintenance Therapy trials Research Report on Maintenance Therapy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia
BN104 monotherapy - Menin Inhibitors, Post Hematopoietic Stem Cell Transplantation
Phase 2RecruitingThe First Affiliated Hospital of Soochow University602025-08-012025-08-03
Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
Initial treatment: PD-1+ Oxaliplatin-based chemotherapy (CAPOX/SOX/FOLFOX), Maintenance treatment (after 3 months): fruquintinib+PD-1 - Gastric Adenocarcinoma, GEJ Adenocarcinoma
Phase 2Not yet recruitingRuijin Hospital552025-03-312025-03-21
A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma
Zanubrutinib - Mantle Cell Lymphoma, Maintenance Therapy
Phase 2RecruitingFudan University522024-05-242024-09-04

Narrower conditions

Lymphoma, Mantle-Cell (1)

Broader conditions

Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Maintenance (1)  ·  zanubrutinib (1)

Sponsors

Fudan University (1)  ·  Ruijin Hospital (1)  ·  The First Affiliated Hospital of Soochow University (1)

Countries

China (3)

Top investigators

Su-ning Chen, M.D. (1)  ·  Yizhen Liu, M.D., Ph.D. (1)